Acquired Chiari I malformation and syringomyelia after valveless lumboperitoneal shunt in infancy

Laurent Riffaud1, Carolina Moughty, Pierre-Louis Henaux

  • 1Department of Neurosurgery, Pontchaillou University Hospital, Rennes, France. laurent.riffaud@chu-rennes.fr <laurent.riffaud@chu-rennes.fr>

Pediatric Neurosurgery
|March 21, 2008
PubMed

Insights

A valveless lumboperitoneal shunt in a child led to acquired Chiari I malformation and syringomyelia. Adjusting the shunt resolved symptoms, highlighting risks of CSF leakage from such devices.

Area of Science:

  • Neurology
  • Neurosurgery
  • Pediatric Medicine

Background:

  • Lumboperitoneal (LP) shunts are used to treat conditions like hydrocephalus and macrocephaly in children.
  • Valveless LP shunts are sometimes preferred for their simplicity.
  • Acquired Chiari I malformation and syringomyelia are serious neurological conditions.

Observation:

  • A 13-year-old boy with a history of a valveless LP shunt developed disabling postural headaches.
  • Neurological examination revealed Chiari I malformation, syringomyelia, and cervical spinal cord edema.
  • Clamping the existing shunt temporarily worsened symptoms, indicating increased intracranial pressure.

Findings:

  • The patient's symptoms were attributed to a symptomatic acquired Chiari I malformation and syringomyelia.
  • These conditions were likely caused by chronic cerebrospinal fluid (CSF) leakage from the valveless LP shunt.
  • Insertion of an adjustable valve shunt (110 mm Hg) successfully resolved all neurological symptoms.

Implications:

  • This case highlights the potential risk of symptomatic acquired Chiari I malformation and syringomyelia associated with valveless LP shunts.
  • Careful consideration and monitoring are necessary when using LP shunts in pediatric patients, particularly those without valves.
  • Management of CSF shunts requires precise pressure regulation to prevent complications such as spinal CSF leaks and secondary malformations.

Related Concept Videos